Equity Overview
Price & Market Data
Price: $0.041
Daily Change: $0.00 / 0.00%
Daily Range: $0.041 - $0.041
Market Cap: $1,640,742
Daily Volume: 10,000
Performance Metrics
1 Week: -6.93%
1 Month: -15.57%
3 Months: -17.94%
6 Months: -14.69%
1 Year: -48.62%
YTD: -17.94%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.